Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06274632 · ClinicalTrials.gov registry record · NA

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV

A NA study of HIV/AIDS, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT06274632 is a NA study of HIV/AIDS that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 250 participants, below the 33,177-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06274632, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, 5 reminder phone calls). We will evaluate the overall effectiveness of ADELANTE compared with ECC on rates of viral suppression and emergency room visits and hospitalizations. Our hypothesis is that ADELANTE participants will achieve higher rates of viral suppression and will have lower rates of emergency room visits and hospitalizations compared with ECC at 12 months post-randomization.

Conditions Studied

HIV/AIDS

Interventions

  • BEHAVIORAL ADELANTE

Study Locations (2)

Florida

  • University of Miami - Miami

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-05-22
Est. Completion 2027-02-28
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06274632

The ClinicalTrials.gov registry entry for NCT06274632 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,177-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which ADELANTE is the first listed.

NCT06274632 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Texas.

Frequently Asked Questions

What is clinical trial NCT06274632 about?

NCT06274632 is a clinical study titled "ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV". The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, 5 reminder phone cal...

What is the current status of trial NCT06274632?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-05-22. Estimated completion is 2027-02-28.

What conditions does trial NCT06274632 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT06274632?

The interventions under investigation include: ADELANTE (BEHAVIORAL).

Who is sponsoring clinical trial NCT06274632?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06274632 being conducted?

This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV/AIDS

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.